127 related articles for article (PubMed ID: 9215466)
1. Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators.
Emonson DL
Aviat Space Environ Med; 1997 Jul; 68(7):606-8. PubMed ID: 9215466
[TBL] [Abstract][Full Text] [Related]
2. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
3. [Activated protein C resistance: role in venous and arterial thrombosis].
Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
[TBL] [Abstract][Full Text] [Related]
4. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
Spannagl M; Schramm W
Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
[No Abstract] [Full Text] [Related]
5. [A newly discovered blood coagulation disorder. Resistance to activated protein C as a cause of thrombosis].
Dahlbäck B; Svensson PJ
Lakartidningen; 1994 Jan; 91(1-2):50-3. PubMed ID: 8289554
[No Abstract] [Full Text] [Related]
6. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
7. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
[TBL] [Abstract][Full Text] [Related]
8. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
[No Abstract] [Full Text] [Related]
9. Resistance to activated protein C: role in venous and arterial thrombosis.
Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
Khogali I; Summerfield GP; Mudawi A
Br J Surg; 1998 Aug; 85(8):1160; author reply 1161. PubMed ID: 9718028
[No Abstract] [Full Text] [Related]
11. A case of deep vein thrombosis in idiopathic nephrotic syndrome with resistance to activated protein C.
Campisi S; Cavatorta F
J Nephrol; 1998; 11(2):76-7. PubMed ID: 9589377
[TBL] [Abstract][Full Text] [Related]
12. [Activated protein C resistance and mutation of coagulation factor V].
Samama MM
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
[No Abstract] [Full Text] [Related]
13. [Venous thrombosis in a pregnant woman heterozygous for factor V Q506 mutation].
Chabane MH; Alhenc-Gelas M; Pathier D; Siguret V; Andreux JP; Gaussem P
Ann Biol Clin (Paris); 1998; 56(1):112-3. PubMed ID: 9754234
[No Abstract] [Full Text] [Related]
14. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
Sulaiman-Shoab S
Br J Surg; 1998 Aug; 85(8):1161. PubMed ID: 9718029
[No Abstract] [Full Text] [Related]
16. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.
Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M
Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991
[TBL] [Abstract][Full Text] [Related]
17. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
[TBL] [Abstract][Full Text] [Related]
18. [Recurrent venous thrombosis in 2 Hungarian protein C-deficient families].
Domján G; Gruber A; Blaskó G; Petö I; Sas G
Orv Hetil; 1985 Dec; 126(52):3191-3. PubMed ID: 2934677
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression.
Peus D; von Schmiedeberg S; Pier A; Scharf RE; Wehmeier A; Ruzicka T; Krutmann J
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):306-9. PubMed ID: 8698912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
